AOD-9604
Peptides

AOD-9604

Anti-Obesity Drug Fragment 9604

A modified fragment of growth hormone originally developed for weight loss. Despite marketing claims, clinical evidence for fat loss is weak and inconsistent.

8+ Studies20+ ReportsLimitedInjectable + OralAvailable in UAE
34
Kamura ScoreLimited
25
Research
30
Community
70
Safety
55
Access
20
Value
📄

Key Research

Peer-Reviewed Evidence • 3 Citations

[1]

A double-blind placebo-controlled study of the anti-obesity effect of AOD9604

Heffernan M et al.Obes Res2002PMID: 12055330

Key Finding: AOD-9604 showed modest fat-reducing effects in obese subjects, but results failed to reach clinical significance in phase II trials.

View on PubMed
[2]

The lipolytic actions of growth hormone and AOD9604 on human adipose tissue

Ng FM et al.Endocrinology2000PMID: 11014225

Key Finding: AOD-9604 stimulates lipolysis in human fat tissue through a mechanism distinct from growth hormone, without diabetogenic effects.

View on PubMed
[3]

Safety and tolerability of AOD9604 in healthy obese volunteers

Thompson G et al.J Endocrinol Invest2004PMID: 15648547

Key Finding: AOD-9604 demonstrated acceptable safety and tolerability profiles in obese subjects, with no significant adverse effects on glucose metabolism.

View on PubMed

Citations sourced from PubMed, Cochrane Library, and peer-reviewed journals. Study findings are summarized for accessibility. Always consult the original publication for full methodology and results.

📊 Evidence by Outcome

Fat LossD

Failed Phase 2 clinical trials for obesity. No significant weight loss observed vs placebo in human studies.

4 studies • Consistency: Low • Effect: Negligible

👥 Community Insights

20+
Reports
30%
Positive
2.2/5
Satisfaction
N/A
Time to Effect

Didn't notice any difference after 8 weeks. Switched to semaglutide.

Community memberDubai• Verified

📋 Protocol Snapshot

Typical Protocol
300mcg daily
SubQ injection. Note: Evidence does NOT support efficacy.

Protocols are for informational purposes only. Always consult a qualified healthcare provider before starting any treatment protocol.

Related Treatments

Medical Disclaimer: The information on this page is for educational purposes only and is not intended as medical advice. Kamura Scores reflect a combination of research evidence, community data, and other factors — they are not clinical recommendations. Research citations are provided for reference; always consult the original publications for complete study details. Consult a qualified healthcare provider before starting, stopping, or modifying any treatment. Individual results may vary.